Standardising acute myeloid leukaemia classification systems: a perspective from a panel of international experts.

Filiaciones

Shallis RM:

Department of Internal Medicine, Section of Hematology, Yale School of Medicine and Yale Cancer Center, New Haven, CT, USA

Daver N:

Department of Leukemia, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA

Altman JK:

Division of Hematology and Oncology, Robert H. Lurie Comprehensive Cancer, Northwestern University Feinberg School of Medicine, Chicago, IL, USA

Komrokji RS:

Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA

Pollyea DA:

Division of Hematology, Department of Medicine, University of Colorado School of Medicine, Aurora, CO, USA

Badar T:

Division of Hematology & Medical Oncology, Mayo Clinic Cancer Center, Jacksonville, FL, USA

Bewersdorf JP:

Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA

Bhatt VR:

Department of Internal Medicine, Division of Hematology-Oncology, University of Nebraska Medical Center, Omaha, NE, USA

de Botton S:

Gustave Roussy Cancer Center, Villejuif, France

de la Fuente Burguera A:

MD Anderson Cancer Center, Madrid, Spain

Carraway HE:

Leukemia Program, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA

Desai P:

Division of Hematology and Oncology, Weill Cornell Medical College, New York, NY, USA

Dillon R:

Department of Medical and Molecular Genetics, King's College, London, UK

Duployez N:

Laboratory of Hematology, Centre Hospitalier Universitaire Lille, Lille, France

El Chaer F:

Department of Medicine, Division of Hematology and Oncology, University of Virginia School of Medicine, Charlottesville, VA, USA

Fathi AT:

Massachusetts General Hospital Cancer Center, Boston, MA, USA

Freeman SD:

Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK

Gojo I:

Division of Hematologic Malignancies, Department of Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA

Grunwald MR:

Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA

Jonas BA:

Department of Internal Medicine, Division of Malignant Hematology, Cellular Therapy and Transplantation, University of California Davis, Davis, CA, USA

Konopleva M:

Montefiore Einstein Cancer Center & Albert Einstein College of Medicine, New York, NY, USA

Lin TL:

Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas, Kansas City, KS, USA

Mannis GN:

Division of Hematology, Department of Medicine, Stanford University, Stanford, CA, USA

Mascarenhas J:

Tisch Cancer Institute, Division of Hematology and Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA

Michaelis LC:

Division of Hematology and Oncology, Froedtert Hospital, Medical College of Wisconsin, Milwaukee, WI, USA

Mims AS:

Division of Hematology, Department of Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA

Montesinos P:

Hospital Universitari i Politècnic La Fe, Valencia, Spain

Pozdnyakova O:

Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA

Pratz KW:

Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA

Schuh AC:

Cancer Clinical Research Unit, Princess Margaret Cancer Centre, Toronto, ON, Canada

Sekeres MA:

Division of Hematology, Sylvester Cancer Center, University of Miami, Miami, FL, USA

Smith CC:

Division of Hematology and Oncology, Department of Medicine, University of California San Francisco, San Francisco, CA, USA

Stahl M:

Leukemia Division, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA

Subklewe M:

Department of Medicine III, University Hospital, Ludwig Maximilian University Munich, Munich, Germany

Uy GL:

Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, MO, USA

Voso MT:

Department of Biomedicine and Prevention, Tor Vergata University, and Neuro-Oncohematology Unit, Istituto di Ricovero e Cura a Carattere Scientifico Fondazione Santa Lucia, Rome, Italy

Walter RB:

Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA

Wang ES:

Leukemia Service, Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA

Zeidner JF:

University of North Carolina, Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA

Žucenka A:

Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania and Institute of Clinical Medicine, Vilnius, Lithuania

Zeidan AM:

Department of Internal Medicine, Section of Hematology, Yale School of Medicine and Yale Cancer Center, New Haven, CT, USA